Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alabama for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alabama only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alabama (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Matthew Oltmanns (NPI 1063603322)

Field	Value
Entity Type	Individual
Organization	Matthew Oltmanns
Address	2208 University Blvd Ste 101
City	Birmingham
State	AL
ZIP	35233
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	August 1, 2007

Payer Source	Total Paid
Medicare	$1.6M
Medicaid	$0

Key Findings

This provider is effectively a single‑payer Medicare clinician: lifetime Medicare revenue is reported as $1.6M and there is no Medicaid billing on file, meaning Medicaid does not materially contribute to this provider’s revenue mix. The dataset therefore reflects a Medicare-centric practice profile rather than a dual‑payer operation.

Revenue is highly concentrated in a small set of procedure/drug codes: the precomputed top 3 Medicare codes account for 80.2% of this provider's total Medicare revenue. Those top drivers are J0178 ($956.3K, 58.2%), J2777 ($233.2K, 14.2%), and 67028 ($127.2K, 7.7%), indicating most income is tied to intravitreal therapies and related in‑office procedures.

Service-line mix is consistent with a retina practice focused on in‑office intravitreal pharmacotherapy and diagnostic imaging: high revenue and claim counts for J0178 (aflibercept), J2777 (faricimab), and presence of J9035 (bevacizumab) and J7312 (dexamethasone implant) show a pharmacologic, injection‑based workload, while 92134 and other retinal imaging codes support ongoing monitoring and treatment decisions. The combination of frequent injection codes and retinal imaging suggests a clinic workflow built around repeat injections and surveillance.

92134 (retinal computerized diagnostic imaging) is an outlier in national context: it appears as an "extreme outlier, far above typical national volume" with 2.4K claims and $65.3K revenue and ranks #709 of 26868 providers nationally (97th percentile). This unusually high imaging volume implies heavy surveillance and monitoring activity that likely supports the clinic’s injection throughput.

Office visit E/M activity also runs well above typical for national peers: 99213 shows 729 claims, $43.7K revenue and ranks #13090 of 457151 providers nationally (97th percentile) with the label "notably above typical national volume." That elevated E/M volume indicates significant established‑patient follow‑up throughput in addition to procedure visits.

The practice performs relatively few major retinal surgeries: vitrectomy and related procedure codes such as 67042 (21 claims, $17.6K) and 67036 (16 claims, $9.4K) are present but account for small shares of revenue. This pattern suggests the practice is primarily office‑based with occasional surgical cases rather than a high‑volume surgical retina center.

Competitive standing across key codes is mixed: the largest revenue driver J0178 ($956.3K, 58.2%) ranks #904 of 3204 providers nationally (72th percentile) and is characterized as "typical, unremarkable volume," so the provider is not a national outlier on aflibercept use despite that drug dominating revenue. By contrast, J9035 (bevacizumab) ranks #107 of 1852 providers nationally (94th percentile) and 92134 is an extreme outlier, indicating pockets of above‑typical activity in imaging and certain drugs even though overall injection volumes for J0178 are typical.

The provider has an established NPI history, enumerated on 2007-08-01 (~19 years ago), which suggests a long tenure in the market and likely an established referral and patient base; combined with the concentrated revenue profile, this implies a stable, injection‑centric retina practice rather than a recently formed or surgical‑heavy operation.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,390	$690	$956.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	8,040	$30	$233.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,460	$90	$127.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,420	$30	$65.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	620	$80	$50.3K
J9035	Injection, bevacizumab, 10 mg	840	$60	$46.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	730	$60	$43.7K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	250	$160	$39.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	280	$90	$25.2K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$840	$17.6K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alabama Distribution

Matthew Oltmanns — 2 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alabama

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	9	40	920	$690	$706.2K
J2777	9	20	7,140	$30	$267.9K
67028	9	40	990	$90	$82.5K
J7312	5	10	280	$150	$63.3K
67042	10	20	20	$940	$24.6K
J9035	7	40	410	$50	$24.5K
99214	1,856	7,330	120	$80	$16.8K
92014	27	430	100	$80	$13.3K
67036	8	20	20	$690	$12.4K
92235	8	10	50	$90	$10.7K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Matthew Oltmanns, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Uahsf Neonatology	AL	Neonatal-Perinatal Medicine Physician	$0	$94M
University Of Alabama Health Services Foundation, PC	AL	Pediatrics Physician	$0	$79.6M
University Of Alabama Health Services Foundation, PC.	AL	Multi-Specialty Clinic/Center	$0	$77.1M
University Of Alabama Health Services Foundation PC	AL	Clinic/Center	$0	$18.6M
University Of Alabama Ophthalmology Services Foundation	AL	Ophthalmology Physician	$0	$6.9M
University Of Alabama At Birmingham	AL	Clinical Medical Laboratory	$2.9K	$3.2M
Andrew Mcfarland	VA	Retina Specialist (Ophthalmology) Physician	$3.1M	$0
Daniel Bennett	NC	Retina Specialist (Ophthalmology) Physician	$3M	$0
Chelsea Cockrell	MS	Family Nurse Practitioner	$3M	$0
Daniel Kasuga	TX	Retina Specialist (Ophthalmology) Physician	$2.9M	$0

Nearby Providers

Other providers in the same ZIP code as Matthew Oltmanns, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Laboratory Corporation Of America Holdings	AL	Clinical Medical Laboratory	$60.5M	$289.1M
The Children's Hospital Of Alabama	AL	Children's Hospital	$0	$59M
M&o Enterprises LLC	AL	Home Infusion Therapy Pharmacy	$0	$31.2M
Medical Resources, Inc	AL	Oxygen Equipment & Supplies (DME)	$0	$23.6M
Southern Lab Partners, LLC	AL	Clinical Medical Laboratory	$5.4M	$14.4M
Jefferson County Board Of Health	AL	Public Health or Welfare Agency	$0	$12.2M
The Children's Hospital Of Alabama	AL	Psychologist	$0	$12M
The Children's Hospital Of Alabama	AL	Pediatrics Physician	$0	$7.5M
Pediatric Anesthesia Associates PC	AL	Anesthesiology Physician	$0	$7.2M
Pediatric Radiology Associates PC	AL	Pediatric Radiology Physician	$0	$6.8M

Matthew Oltmanns — Billing Profile & Reimbursement Data

Sign up for Matthew Oltmanns — Billing Profile & Reimbursement Data policy alerts

Matthew Oltmanns — Billing Profile & Reimbursement Data

Sign up for Matthew Oltmanns — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References